USA flag logo/image

An Official Website of the United States Government

SBIR Phase I: High throughput microfluidic cell injection for cell reprogramming

Award Information

Agency:
National Science Foundation
Branch:
N/A
Award ID:
98805
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
0944910
Solicitation Year:
N/A
Solicitation Topic Code:
BT
Solicitation Number:
N/A
Small Business Information
Zaiput
955 Massachusetts Ave # 318 Cambridge, MA 02139-3233
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: SBIR Phase I: High throughput microfluidic cell injection for cell reprogramming
Agency: NSF
Contract: 0944910
Award Amount: $150,000.00
 

Abstract:

This Small Business Innovation Research (SBIR) Phase I project supports research aimed at developing a new technology to deliver material into living cells. Delivery of material into living cells is a limiting step in a number of biological applications and innovative therapeutic approaches, including stem cells based therapy and regenerative medicine. In this project a novel technology to allow high throughput delivery of any type of molecule into any type of cell is explored. In this innovative system, living cells are lined up by flowing them in a microfluidic channel and the material to be delivered is shot on the cells with a miniaturized fluid jet that carries the molecules of interest. The broader impacts of this research are expected in the field of stem cell research and stem cell-based therapy. In particular, this microfluidic based system has the potential to boost the generation of induced pluripotent stem cells (iPS) , the rising star in the field of regenerative medicine, by eliminating the intracellular delivery problems that currently make generation of these cells extremely inefficient. Besides helping the biomedical community in realizing the commercial potential of iPS, the availability of the new intracellular delivery technology could benefit many different fields of biology, ranging from molecular biology to pharmaceutical research, and enable a number of new research applications.

Principal Investigator:

Andrea Adamo
PhD
6172304596
andrea.adamo@gmail.com

Business Contact:

Andrea Adamo
PhD
6172304596
andrea.adamo@gmail.com
Small Business Information at Submission:

Zaiput
955 Massachusetts Ave # 318 Cambridge, MA 02139

EIN/Tax ID: 270296902
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No